Anticoagulants beyond coagulation: a narrative review of cardiovascular effects. [PDF]
Aarts A, Ten Cate H, Ten Cate-Hoek AJ.
europepmc +1 more source
Response to Tutorial Drug-Drug Interactions by EM Sellers. [PDF]
Das JL, Ajavon-Hartmann AT, Schmith VGD.
europepmc +1 more source
Tutorial on non inferiority trial in pharmaceutical research: an important and applied issue. [PDF]
Madadizadeh F, Afzal G.
europepmc +1 more source
Letter to the editor regarding "Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study" by Purrucker et al. [PDF]
Zupan M, Šabovič M, Frol S.
europepmc +1 more source
Predictors of Direct Oral Anticoagulant Use in Northern Italy: A Population-Based Study. [PDF]
Ojeda-Fernández L +6 more
europepmc +1 more source
Translation of a physiologically-based pharmacokinetic model for dabigatran etexilate to the design of a safety and efficacy study in post-partum women. [PDF]
Ogungbenro K +3 more
europepmc +1 more source
Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI). [PDF]
Liang M +30 more
europepmc +1 more source
Direct oral anticoagulant interference and removal in the factor VIII inhibitor assay. [PDF]
Timmerije R +5 more
europepmc +1 more source
Is there a role for anticoagulation with dabigatran in S. aureus bacteremia? Protocol for the adjunctive treatment domain of the <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) randomised controlled trial. [PDF]
McDonald EG +13 more
europepmc +1 more source
Management of Recurrent Venous Thromboembolism on Anticoagulation. [PDF]
Eatrides J +6 more
europepmc +1 more source

